$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Dec 10, 2025)
$144.21M
Market Cap
-
P/E Ratio
-0.77
EPS
$1.80
52 Week High
$0.75
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Lucid Diagnostics Inc. is a pioneering medical diagnostic technology company based in New York, focused on revolutionizing early cancer detection and improving patient care. The company leverages cutting-edge technologies to develop innovative diagnostic tests that support informed clinical decision-making and enhance patient outcomes within the oncology field. With its dedication to addressing significant unmet needs in healthcare, Lucid Diagnostics is strategically positioned to be a vital player in the evolving medical diagnostics landscape, driving advancements that could reshape treatment methodologies and improve the quality of care for patients facing cancer.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
SOFI
CFLT
ADAP
BAC
PFE
MARA
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
CXAI
IREN
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
SLM
NVTS
AGNC
NCLH
HOOD
PCG
PLTR
CPB
AMCR
PLTD
JPM
RXRX
SMCI
GPK
ORCL
PAAS
NOK
UBER
MU
RKLB
WFC
HL
VICI
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
SOFI
CFLT
ADAP
BAC
PFE
MARA
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
CXAI
IREN
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
SLM
NVTS
AGNC
NCLH
HOOD
PCG
PLTR
CPB
AMCR
PLTD
JPM
RXRX
SMCI
GPK
ORCL
PAAS
NOK
UBER
MU
RKLB
WFC
HL
VICI